Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Labeling Is Critical As Bump From Compendia Listing Diminishes – Genentech

Executive Summary

Listing off-label uses in compendia may no longer provide the same bump in sales that would have been seen in the past, Genentech Exec VP - Commercial Operations Ian Clark said
Advertisement

Related Content

Avastin Experience Clarifies FDA Concerns With Cooperative Group Trials
Avastin Experience Clarifies FDA Concerns With Cooperative Group Trials
Roche Keeps Lifecycle Management In Motion For Oncology Portfolio
Roche Sees Avastin As Oncology Backbone, Will Focus On Combinations
Ovarian Progression-Free Survival Acceptable If Trial Is Powered For Survival
CMS Extends Oncology Demo, Shifts Focus To Clinical Guideline Adherence
CMS Extends Oncology Demo, Shifts Focus To Clinical Guideline Adherence
Advertisement
UsernamePublicRestriction

Register

PS047388

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel